Close Menu

More articles about Infectious Disease

The Swiss foundation has become a member of the CPGR in order to develop point-of-care tests for African diseases.

While companies selling array-based tests, including CombiMatrix, Arrayit, and Veredus Labs, are keen to make their platforms available to laboratories for identifying the flu strain, the FDA has only given emergency use authorization for a PCR-based test. Moreover, companies that sell flu chips are unlikely to see their technology adopted unless the current swine flu strain mutates, according to some sources.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Short Reads: May 1, 2009

Premium

News in brief

IP Update: Apr 30, 2009

Premium

USPTO Publishes One Patent, Seven Patent Applications Related to RNAi

The CDC's assay will run on ABI's 7500 Fast Dx Real-Time PCR instrument or the research use only 7500 Real-Time PCR instrument.

The test has not been cleared for marketing by FDA, but the agency granted the US Centers for Disease Control and Prevention the authority to use the multiplex panel to diagnose patients in the US.

Over the next year, the company hopes to open three more sequencing labs in partnership with biology researchers, probably in Thailand, Mexico, and France, for which it will provide bioinformatics services through its Houston facility.

The test simultaneously identifies Mycobacterium tuberculosis and resistance to first-line drug therapy rifampicin.

Merck, Medarex, and UMass' MBL Ink mAb deal; Vandy licenses cancer Rx assay to DiaTech; MolecularMD sub-licenses OHSU CML mutation test to Mayo Clinic, and more …

Officials from Billerica, Mass.-based Aushon Biosystems and Roslin, UK-based Arrayjet separately told BioArray News this week that, in spite of overall market conditions, they are seeing increasing demand for arrayers from pharmaceutical and biotech companies as well as academics.

Qiagen will provide its HPV molecular assays for use in the new screening program.

Qiagen licensed HandyLab's extraction technology for use in the sample prep process for its HPV assays.

Oregon Health and Science University will use a $41M grant to start a regional biodefense and infectious disease center.

MTTC links up with iBridge Network; ViroStatics licenses compound library from University of Siena; Ben-Gurion University inks research pact with Bayer CropScience, and more …

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The first in a series of programs will support studies of HIV-1 persistence, including host and pathogen genetics.

Nearly $14 million next year will support centers to study malaria and develop gene-based diagnostics.

Short Reads: Apr 7, 2009

Premium

Genome Analysis Centre, University of Barcelona, NIAID, Massachusetts Institute of Technology, J. Craig Venter Institute, University of Maryland, SeqWright, Hologic, BioReference Laboratories, GeneDx, University of Michigan, Genomatix Software, NHGRI

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.